AAAAAA

   
Results: 1-13 |
Results: 13

Authors: WOLK DA MISELJIC S CIVELEK AC PORT JD CHIN BB MCARTHUR JC
Citation: Da. Wolk et al., DIAGNOSTIC UTILITY OF TL-201 IN HIV-ASSOCIATED MASS LESIONS, Neurology, 50(4), 1998, pp. 4055-4055

Authors: WITTLIFF JL MISELJIC S CUMMINS JA PASIC R
Citation: Jl. Wittliff et al., DOES MENOPAUSAL STATUS INFLUENCE SEX-STEROID RECEPTOR CONTENT AND SPECIFIC-BINDING CAPACITY, Journal of clinical ligand assay, 19(3), 1996, pp. 203-207

Authors: SANFILIPPO JS MISELJIC S YANG AR DOERING DL SHAHEEN RM WITTLIFF JL
Citation: Js. Sanfilippo et al., QUANTITATIVE-ANALYSES OF EPIDERMAL GROWTH-FACTOR RECEPTORS, HER-2 NEUONCOPROTEIN AND CATHEPSIN-D IN NONMALIGNANT AND MALIGNANT UTERI/, Cancer, 77(4), 1996, pp. 710-716

Authors: MISELJIC S CAVAZOS AS WITTLIFF JL
Citation: S. Miseljic et al., MENOPAUSAL INFLUENCE ON EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTORS, HER-S NEU ONCOPROTEIN, AND CATHEPSIN-D IN BREAST-CANCER/, Journal of clinical ligand assay, 18(3), 1995, pp. 176-180

Authors: MISELJIC S GALANDIUK S YANG AR FIECHTER J WITTLIFF JL
Citation: S. Miseljic et al., PROTEIN MARKERS FOR MALIGNANT TRANSFORMATION OF THE COLON, Journal of clinical ligand assay, 18(2), 1995, pp. 135-140

Authors: SHAHEEN RM MISELJIC S DOERING DL WITTLIFF JL
Citation: Rm. Shaheen et al., COMPARISON OF CATHEPSIN-D DETERMINATIONS IN HUMAN CARCINOMAS BY ENZYME-IMMUNOASSAY AND IMMUNORADIOMETRIC ASSAY, Journal of clinical laboratory analysis, 9(6), 1995, pp. 351-358

Authors: MISELJIC S GALANDIUK S MYERS SD WITTLIFF JL
Citation: S. Miseljic et al., EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN COLON-DISEASE, Journal of clinical laboratory analysis, 9(6), 1995, pp. 413-417

Authors: SEWELL CL MARTIN AW MISELJIC S WITTLIFF JL
Citation: Cl. Sewell et al., AGREEMENT OF EGF RECEPTOR DETERMINATIONS BY IMMUNOHISTOCHEMISTRY AND RADIOLIGAND-BINDING, Laboratory investigation, 72(1), 1995, pp. 141-141

Authors: MISELJIC S GALANDIUK S MYERS SD WITTLIFF JL
Citation: S. Miseljic et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAL-1) EXPRESSION IN COLON DISEASES, Clinical chemistry, 41(6), 1995, pp. 224-224

Authors: SHAHEEN RM MISELJIC S WIEHLE RD WITTLIFF JL
Citation: Rm. Shaheen et al., RELATION BETWEEN CATHEPSIN-D EXPRESSION AND OTHER PROGNOSTIC FACTORS IN BREAST CARCINOMAS, Clinical chemistry, 41(11), 1995, pp. 1585-1591

Authors: THEUER HH LEAR SC MARTIN AW MISELJIC S WITTLIFF JL
Citation: Hh. Theuer et al., DETECTION OF CATHEPSIN-D IN INFILTRATING DUCT BREAST-CARCINOMA - IMMUNOHISTOCHEMISTRY VERSUS ENZYME-IMMUNOASSAY, Laboratory investigation, 70(1), 1994, pp. 10000023-10000023

Authors: SHAHEEN RM MISELJIC S WITTLIFF JL
Citation: Rm. Shaheen et al., EXPRESSION OF CATHEPSIN-D IN HUMAN ENDOMETRIAL AND OVARIAN CARCINOMAS, Clinical research, 41(3), 1993, pp. 10000710-10000710

Authors: GALANDIUK S MISELJIC S YANG AR EARLY M MCCOY MD WITTLIFF JL
Citation: S. Galandiuk et al., EXPRESSION OF HORMONE RECEPTORS, CATHEPSIN-D, AND HER-2 NEU ONCOPROTEIN IN NORMAL COLON AND COLONIC DISEASE/, Archives of surgery, 128(6), 1993, pp. 637-642
Risultati: 1-13 |